Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas
Author Information
Author(s): Kilvaer Thomas Karsten, Valkov Andrej, Sorbye Sveinung W., Donnem Tom, Smeland Eivind, Bremnes Roy Martin, Busund Lill-Tove
Primary Institution: University of Tromsø
Hypothesis
This study investigates the prognostic impact of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in non-GIST STS patients with wide and nonwide resection margins.
Conclusion
High expression of PDGF-B and the coexpression of PDGF-B and PDGFR-α are strong and independent prognostic factors in non-GIST STSs with wide resection margins.
Supporting Evidence
- High expression of PDGF-B was found to be a significant negative prognostic indicator of disease-specific survival.
- The coexpression of PDGF-B and PDGFR-α was a significant independent negative prognostic indicator of disease-specific survival.
- In the subgroup with wide resection margins, high expressions of PDGF-B and PDGFR-α were significant negative prognostic indicators.
Takeaway
This study found that certain proteins in tumors can help predict how long patients with a specific type of cancer will live, even after surgery.
Methodology
Tumor samples and clinical data from 249 patients were analyzed using immunohistochemistry to evaluate the expression of PDGFs and PDGFRs.
Limitations
The study includes tumor heterogeneity and diverse therapies, which may affect the results.
Participant Demographics
Median age was 59 years, 56% were female, with 167 Norwegian and 82 Russian patients.
Statistical Information
P-Value
P = .013
Confidence Interval
95% CI = 1.255–6.956
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website